Healthcare - Press Releases

Date	Title	Company
16-Dec-2022	SmiLe alumni Acrivon AB’s US parent company Acrivon Therapeutics rings NASDAQ closing bell in New York	SmiLe
16-Dec-2022	Shaw & Co Launches Healthcare & Life Sciences (H&LS) Sector Report	Shaw & Co
15-Dec-2022	PANTHER will pounce on pandemics in remote, at-risk areas before they break	Panther
15-Dec-2022	Data Shows 50% of New Trials Have Sites in Asia Pacific	Novotech Health Holdings Pte Ltd
15-Dec-2022	Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding	Verseon International Corporation
14-Dec-2022	Targeted Timing of Palliative Care for Lung Cancer	KL Krems
14-Dec-2022	Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture	SAE Media Group
14-Dec-2022	ABBOTT AND THE BRAIN INJURY ASSOCIATION OF AMERICA LAUNCH CONCUSSION AWARENESS NOW COALITION; TEAM UP WITH REBEL WILSON TO RAISE AWARENESS ON SERIOUSNESS OF CONCUSSIONS	ABBOTT
14-Dec-2022	Aston University biochemist explains why oxygen is an essential but stressful element - public lecture	Aston University
13-Dec-2022	Homelessness is leading to a health crisis	University of Kent
13-Dec-2022	Scottish Medicines Consortium (SMC) Extends Advice Accepting RINVOQ®▼(upadacitinib) For Treatment of Adults with Moderate Rheumatoid Arthritis	AbbVie
13-Dec-2022	DAVID BROCKLEHURST APPOINTED HEAD OF ONCOLOGY AT ASTRAZENECA UK	AstraZeneca
13-Dec-2022	Inizio acquires Evolution Road, bolstering Evoke’s digital innovation and omnichannel offering	Inizio
13-Dec-2022	Wellness Access Institute launches to accelerate the speed of innovation from the science to shopper	Wellness Access Institute
13-Dec-2022	Strep A outbreak – expert warns ‘knee-jerk’ antibiotic treatments may do more harm than good	London Medical Laboratory
13-Dec-2022	Diabetes self-management app intellin® is a cost-effective solution for preventing diabetic foot ulcer recurrence	Gendius
13-Dec-2022	1ST Biotherapeutics, Inc., Announces FDA Clearance of IND Application for Phase 1/2 Study of FB849 to Treat Patients with Advanced Solid Tumors	1ST Biotherapeutics, Inc.
12-Dec-2022	Utrogestan 100mg (micronised progesterone) capsules accepted by SMC for use as HRT in Scotland	Besins Healthcare UK
12-Dec-2022	Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing	Legend Capital
09-Dec-2022	Moderna Receives FDA Emergency Use Authorization for Omicron-Targeting Bivalent COVID-19 Booster Vaccine in Children 6 Months Through 5 Years of Age	Moderna, Inc.